Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.70 |
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.68 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.68 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.68 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.68 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 5/20 | 0.49 |
| ▸ | MMP3 | P08254 | 5/20 | 0.49 |
| ▸ | MMP2 | P08253 | 4/20 | 0.49 |
| ▸ | MMP7 | P09237 | 3/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19910585 | 1.00 | CA2 (0.70) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL24932772 | 1.00 | CA2 (0.70) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20915578 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20915253 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20915289 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20936513 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20915508 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL21389651 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL20936460 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 | |
| SCHEMBL10697539 | 0.92 | CA2 (0.85) | CA2CA1HDAC8HDAC6HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5174917-A | Compositions containing n-ethyl hydroxamic acid chelants | MONSANTO COMPANY (US) | 1992-12-29 | — | — | US | claimed |
| EP-0271468-A2 | Gallium complexes and solvent extraction of gallium | Monsanto Company (US) | 1988-06-15 | — | — | EP | claimed |
| US-4741887-A | Gallium complexes and solvent extraction of gallium | MONSANTO COMPANY (US) | 1988-05-03 | — | — | US | claimed |
| US-9618788-B2 | Optical film, polarizing plate and liquid crystal display using the same | FUJIFILM CORPORATION (JP) | 2017-04-11 | — | — | US | disclosed |
| US-20150253621-A1 | OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME | FUJIFILM CORPORATION (JP) | 2015-09-10 | — | — | US | disclosed |
| JP-2001011038-A | NEW ISOCYANATE AND SEMICARBAZIDE EACH HAVING SECONDARY ALKYL CHAIN AND THEIR SYNTHESIS | FUJI PHOTO FILM CO LTD | 2001-01-16 | — | — | JP | disclosed |
| EP-0283740-B1 | Oxidative dissolution of gallium arsenide and separation of gallium from arsenic | MONSANTO CO (US) | 1993-11-24 | — | — | EP | disclosed |
| US-5174917-A | Compositions containing n-ethyl hydroxamic acid chelants | MONSANTO COMPANY (US) | 1992-12-29 | — | — | US | disclosed |
| US-5030427-A | Washing solutions of n-organohydaoxamic acid complexes | MONSANTO COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
| US-4943646-A | WITH N-ORGANOHYDROXAMIC ACID | MONSANTO COMPANY (US) | 1990-07-24 | — | — | US | disclosed |
| US-4939299-A | Succinyl dihydroxamic acids | MONSANTO COMPANY (US) | 1990-07-03 | — | — | US | disclosed |
| EP-0344143-A2 | Gallium purification | MONSANTO COMPANY (US) | 1989-11-29 | — | — | EP | disclosed |
| EP-0283740-A2 | Oxidative dissolution of gallium arsenide and separation of gallium from arsenic | MONSANTO COMPANY (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4759917-A | Contacting with oxidizing agent and hydroxamic acid to convert gallium to gallium-hydroxamic acid complex, and oxidize arsanic | MONSANTO COMPANY (US) | 1988-07-26 | — | — | US | disclosed |
| EP-0271468-A2 | Gallium complexes and solvent extraction of gallium | Monsanto Company (US) | 1988-06-15 | — | — | EP | disclosed |
| US-4741887-A | Gallium complexes and solvent extraction of gallium | MONSANTO COMPANY (US) | 1988-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150253621-A1 | OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME | SSTR3, FFAR3, CNPY3 | CA2 4218/4885CA1 4414/4885HDAC8 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.